Table 2. Trends in complete blood count at the baseline, at the rise of eosinophils, at the peak of eosinophils, and four weeks after starting treatment with tablet Imatinib.
CBC: Complete blood count; TLC: total leukocyte count; AEC: absolute eosinophil count; Hb: hemoglobin.
| Investigation | Baseline Values (8/6/2022) | Rise of Eosinophils (22/7/22) | Peak of Eosinophilia (26/10/2022) | After Treatment With Imatnib (28/11/2022) | Reference Values |
| TLC (per μL) | 9.6*103 | 22.56*103 | 16.2*103 | 8.53 *103 | 4-10 * 103 |
| Neutrophil % | 73 | 86 | 37.9 | 77.5 | 4-80 |
| Lymphocyte % | 20 | 2.2 | 8.9 | 10.1 | 20-40 |
| Monocyte % | 4 | 1 | 5 | 7.9 | 2-10 |
| Eosinophil % | 3 | 10.3 | 47.9 | 3.3 | 1-6 |
| Basophil % | 0 | 0.1 | 0.3 | 1.2 | 0-1 |
| AEC (per μL) | 0.28*103 | 2.33*103 | 7.76 *103 | 0.28 * 103 | 0.02-0.5*103 |
| Hb (g/dl) | 8.8 | 9.4 | 8.7 | 10.6 | 12-15 |
| Platelet (per μL) | 217*103 | 526*103 | 630*103 | 379 *103 | 150-450*103 |